MOXATAG

LOE Approaching

amoxicillin

NDAORALTABLET, EXTENDED RELEASE
Approved
Jan 2008
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
20

Clinical Trials (5)

NCT07308041Phase 1Completed

A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin

Started Nov 2025
12 enrolled
Drug InteractionGERD (Gastroesophageal Reflux Disease)Safety, and Tolerability
NCT05584657Phase 3Completed

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

Started Oct 2022
NCT02332577Phase 4Terminated

Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Started Apr 2015
161 enrolled
Pneumonia
NCT01934231Phase 3Completed

Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis

Started Aug 2013
27 enrolled
Sinusitis, Acute
NCT01491659Phase 4Withdrawn

A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate

Started Jan 2013
0
Diarrhoea

Loss of Exclusivity

LOE Date
May 7, 2027
14 months away
Patent Expiry
May 7, 2027

Patent Records (3)

Patent #ExpiryTypeUse Code
8357394
Dec 8, 2026
Product
8778924
Dec 8, 2026
SubstanceProduct
U-897
8299052
May 7, 2027
U-1304